Marker Therapeutics Inc (MRKR)

[Inoviorulez]

For me an investment in MRKR is a play on longevity. Not only does MultiTAA work but the results I liked most is that all patients that achieved a CR had never relapsed in studies. Meaning those that had cleared their cancer for a long duration of response of 3 or 4 years or more and never relapsed. That's the recruited T-cells with epitope spreading that keeps the killing of the cancer cells going. On the other hand CAR-T patients over time eventually relapse as the engineered T-cells lose longevity.